SACHA

Securing and Accelerating Access to Innovative medicines for Children and Adolescents with Cancer

Advancing access to innovation

Generating real-world evidence

Empowering collaboration

SACHA: a Pediatric Cancer Registry

SACHA (Securing and Accelerating access to innovative therapies for Children and Adolescents with cancer) is an international registry-based study coordinated by Gustave Roussy. It aims to facilitate and secure access to innovative anticancer medicines for children, adolescents and young adults (AYA) outside of clinical trials, while collecting real-world evidence (RWE) of safety and efficacy to inform future research and regulatory decisions.

Opened in France in 2020, SACHA extended across multiple countries from 2023 thanks to Fight Kids Cancer and brings now together pediatric oncology centers committed to Securing Access to Innovation.

Learn about SACHA

SACHA & you

Participating centers and investigators

Access secured documentation and tools.

Go to professional area →

Parent or patient

Understand how SACHA supports innovative treatment pathways.

Learn about SACHA →

Are you interested in joining the SACHA international network, contributing data or becoming a partner?

Contact our team to learn how you can participate in improving access to innovation for children, adolescents and young adults with cancer.

SACHA eligibility criteria

SACHA Patients

Patients are ≤ 25 years-old with a recurrent/refractory pediatric malignancy
Patients are not eligible in a clinical trial or with no therapeutic option available in an ongoing trial
Patients are treated with a new anticancer medicine through either off-label or compassionate use
SACHA treatments are recommended by a multidisciplinary tumor board.